These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 37954592)

  • 1. Of mice and lymphoid aggregates: modeling tertiary lymphoid structures in cancer.
    Vaccaro A; van de Walle T; Ramachandran M; Essand M; Dimberg A
    Front Immunol; 2023; 14():1275378. PubMed ID: 37954592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms of tertiary lymphoid structure formation: cooperation between inflammation and antigenicity.
    Khanal S; Wieland A; Gunderson AJ
    Front Immunol; 2023; 14():1267654. PubMed ID: 37809103
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epigenetic targets to enhance antitumor immune response through the induction of tertiary lymphoid structures.
    Omotesho QA; Escamilla A; Pérez-Ruiz E; Frecha CA; Rueda-Domínguez A; Barragán I
    Front Immunol; 2024; 15():1348156. PubMed ID: 38333212
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune mechanisms orchestrate tertiary lymphoid structures in tumors via cancer-associated fibroblasts.
    Rodriguez AB; Peske JD; Woods AN; Leick KM; Mauldin IS; Meneveau MO; Young SJ; Lindsay RS; Melssen MM; Cyranowski S; Parriott G; Conaway MR; Fu YX; Slingluff CL; Engelhard VH
    Cell Rep; 2021 Jul; 36(3):109422. PubMed ID: 34289373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heterogeneity of tertiary lymphoid structures in cancer.
    You X; Koop K; Weigert A
    Front Immunol; 2023; 14():1286850. PubMed ID: 38111571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mature tertiary lymphoid structures: important contributors to anti-tumor immune efficacy.
    Bao X; Lin X; Xie M; Yao J; Song J; Ma X; Zhang X; Zhang Y; Liu Y; Han W; Liang Y; Hu H; Xu L; Xue X
    Front Immunol; 2024; 15():1413067. PubMed ID: 39026670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophages and tertiary lymphoid structures as indicators of prognosis and therapeutic response in cancer patients.
    Niu L; Chen T; Yang A; Yan X; Jin F; Zheng A; Song X
    Biochim Biophys Acta Rev Cancer; 2024 Sep; 1879(5):189125. PubMed ID: 38851437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Crohn's-Like Lymphoid Reaction to Colorectal Cancer-Tertiary Lymphoid Structures With Immunologic and Potentially Therapeutic Relevance in Colorectal Cancer.
    Maoz A; Dennis M; Greenson JK
    Front Immunol; 2019; 10():1884. PubMed ID: 31507584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tertiary Lymphoid Structures as a Predictive Biomarker of Response to Cancer Immunotherapies.
    Trüb M; Zippelius A
    Front Immunol; 2021; 12():674565. PubMed ID: 34054861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inducible Tertiary Lymphoid Structures: Promise and Challenges for Translating a New Class of Immunotherapy.
    Aoyama S; Nakagawa R; Mulé JJ; Mailloux AW
    Front Immunol; 2021; 12():675538. PubMed ID: 34054863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tertiary lymphoid structures in the era of cancer immunotherapy.
    Sautès-Fridman C; Petitprez F; Calderaro J; Fridman WH
    Nat Rev Cancer; 2019 Jun; 19(6):307-325. PubMed ID: 31092904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tertiary lymphoid structures and B lymphocytes in cancer prognosis and response to immunotherapies.
    N J; J T; Sl N; Gt B
    Oncoimmunology; 2021 Mar; 10(1):1900508. PubMed ID: 33854820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intratumoral tertiary lymphoid structure (TLS) maturation is influenced by draining lymph nodes of lung cancer.
    He M; He Q; Cai X; Liu J; Deng H; Li F; Zhong R; Lu Y; Peng H; Wu X; Chen Z; Lao S; Li C; Li J; He J; Liang W
    J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37072348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tertiary lymphoid structures are critical for cancer prognosis and therapeutic response.
    Zhang Q; Wu S
    Front Immunol; 2022; 13():1063711. PubMed ID: 36713409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. STINGing the Tumor Microenvironment to Promote Therapeutic Tertiary Lymphoid Structure Development.
    Filderman JN; Appleman M; Chelvanambi M; Taylor JL; Storkus WJ
    Front Immunol; 2021; 12():690105. PubMed ID: 34054879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B Cells and Tertiary Lymphoid Structures: Friends or Foes in Cancer Immunotherapy?
    Lauss M; Donia M; Svane IM; Jönsson G
    Clin Cancer Res; 2022 May; 28(9):1751-1758. PubMed ID: 34965949
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tertiary lymphoid structures in anticancer immunity.
    Teillaud JL; Houel A; Panouillot M; Riffard C; Dieu-Nosjean MC
    Nat Rev Cancer; 2024 Sep; 24(9):629-646. PubMed ID: 39117919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tumor-associated tertiary lymphoid structures in cancer: implications for immunotherapy.
    Langouo Fontsa M; Padonou F; Willard-Gallo K
    Expert Rev Clin Immunol; 2024 Aug; 20(8):839-847. PubMed ID: 39007892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphoid aggregates in desmoplastic melanoma have features of tertiary lymphoid structures.
    Stowman AM; Hickman AW; Mauldin IS; Mahmutovic A; Gru AA; Slingluff CL
    Melanoma Res; 2018 Jun; 28(3):237-245. PubMed ID: 29538091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tertiary lymphoid structures in cancer.
    Schumacher TN; Thommen DS
    Science; 2022 Jan; 375(6576):eabf9419. PubMed ID: 34990248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.